• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗性靶向 GDF11 在肌肉萎缩中的作用:研究进展与策略。

Therapeutic targeting of GDF11 in muscle atrophy: Insights and strategies.

机构信息

Lab of Regenerative Medicine in Sports Science, School of Physical Education and Sports Science, South China Normal University, Guangzhou, China.

Lab of Regenerative Medicine in Sports Science, School of Physical Education and Sports Science, South China Normal University, Guangzhou, China.

出版信息

Int J Biol Macromol. 2024 Nov;279(Pt 3):135321. doi: 10.1016/j.ijbiomac.2024.135321. Epub 2024 Sep 3.

DOI:10.1016/j.ijbiomac.2024.135321
PMID:39236952
Abstract

The exploration of novel therapeutic avenues for skeletal muscle atrophy is imperative due to its significant health impact. Recent studies have spotlighted growth differentiation factor 11 (GDF11), a TGFβ superfamily member, for its rejuvenating role in reversing age-related tissue dysfunction. This review synthesizes current findings on GDF11, elucidating its distinct biological functions and the ongoing debates regarding its efficacy in muscle homeostasis. By addressing discrepancies in current research outcomes and its ambiguous role due to its homological identity to myostatin, a negative regulator of muscle mass, this review aims to clarify the role of GDF11 in muscle homeostasis and its potential as a therapeutic target for muscle atrophy. Through a thorough examination of GDF11's mechanisms and effects, this review provides insights that could pave the way for innovative treatments for muscle atrophy, emphasizing the need and strategies to boost endogenous GDF11 levels for therapeutic potential.

摘要

由于骨骼肌萎缩对健康的重大影响,探索新的治疗方法迫在眉睫。最近的研究强调了生长分化因子 11(GDF11)作为转化生长因子-β(TGFβ)超家族成员在逆转与年龄相关的组织功能障碍方面的恢复活力作用。本综述综合了目前关于 GDF11 的研究结果,阐明了其独特的生物学功能以及关于其在肌肉内稳态中的功效的持续争论。通过解决当前研究结果中的差异以及由于其与肌肉质量负调节剂肌生成抑制素(myostatin)的同源性而导致的其作用不明确的问题,本综述旨在阐明 GDF11 在肌肉内稳态中的作用及其作为肌肉萎缩治疗靶点的潜力。通过对 GDF11 的机制和作用进行深入研究,本综述提供了一些见解,为肌肉萎缩的创新治疗方法铺平了道路,强调了提高内源性 GDF11 水平以发挥治疗潜力的必要性和策略。

相似文献

1
Therapeutic targeting of GDF11 in muscle atrophy: Insights and strategies.治疗性靶向 GDF11 在肌肉萎缩中的作用:研究进展与策略。
Int J Biol Macromol. 2024 Nov;279(Pt 3):135321. doi: 10.1016/j.ijbiomac.2024.135321. Epub 2024 Sep 3.
2
A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.一种 GDF11/肌抑素抑制剂,GDF11 前肽-Fc,可增加肌营养不良症 mdx 小鼠的骨骼肌质量并改善肌肉力量。
Skelet Muscle. 2019 May 27;9(1):16. doi: 10.1186/s13395-019-0197-y.
3
Pathophysiological levels of GDF11 activate Smad2/Smad3 signaling and induce muscle atrophy in human iPSC-derived myocytes.生长分化因子11(GDF11)的病理生理水平激活Smad2/Smad3信号通路并诱导人诱导多能干细胞衍生的心肌细胞发生肌肉萎缩。
Am J Physiol Cell Physiol. 2022 Nov 1;323(5):C1402-C1409. doi: 10.1152/ajpcell.00341.2022. Epub 2022 Sep 12.
4
DA-Raf and the MEK inhibitor trametinib reverse skeletal myocyte differentiation inhibition or muscle atrophy caused by myostatin and GDF11 through the non-Smad Ras-ERK pathway.DA-Raf 和 MEK 抑制剂 trametinib 通过非 Smad Ras-ERK 通路逆转肌肉生长抑制素和 GDF11 引起的骨骼肌成肌细胞分化抑制或肌肉萎缩。
J Biochem. 2022 Jan 7;171(1):109-122. doi: 10.1093/jb/mvab116.
5
The role of GDF11 in aging and skeletal muscle, cardiac and bone homeostasis.生长分化因子 11 在衰老及骨骼肌肉、心脏和骨内稳态中的作用。
Crit Rev Biochem Mol Biol. 2019 Apr;54(2):174-183. doi: 10.1080/10409238.2019.1610722.
6
Redundancy of myostatin and growth/differentiation factor 11 function.肌生成抑制蛋白与生长/分化因子11功能的冗余性。
BMC Dev Biol. 2009 Mar 19;9:24. doi: 10.1186/1471-213X-9-24.
7
Growth differentiation factor 11 induces skeletal muscle atrophy via a STAT3-dependent mechanism in pulmonary arterial hypertension.生长分化因子 11 通过 STAT3 依赖机制诱导肺动脉高压中的骨骼肌萎缩。
Skelet Muscle. 2022 May 6;12(1):10. doi: 10.1186/s13395-022-00292-x.
8
The Growth Differentiation Factor 11 (GDF11) and Myostatin (MSTN) in tissue specific aging.组织特异性衰老中的生长分化因子11(GDF11)和肌肉生长抑制素(MSTN)
Mech Ageing Dev. 2017 Jun;164:108-112. doi: 10.1016/j.mad.2017.04.009. Epub 2017 May 1.
9
GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone.GDF11 促进成骨作用,而 MSTN 则相反,Follistatin 是一种 MSTN/GDF11 抑制剂,它可以增加肌肉量但削弱骨骼。
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4910-4920. doi: 10.1073/pnas.1916034117. Epub 2020 Feb 18.
10
Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.肌肉中潜伏性转化生长因子β结合蛋白4的过表达通过肌肉生长抑制素和转化生长因子β改善肌肉萎缩症
PLoS Genet. 2016 May 5;12(5):e1006019. doi: 10.1371/journal.pgen.1006019. eCollection 2016 May.

引用本文的文献

1
Annual Banned-Substance Review 17th Edition-Analytical Approaches in Human Sports Drug Testing 2023/2024.《年度禁用物质审查第17版——2023/2024年人类运动药物检测中的分析方法》
Drug Test Anal. 2025 Aug;17(8):1417-1442. doi: 10.1002/dta.3835. Epub 2024 Dec 28.